The transformation of drug development for the 21st century: Time for a change

Mol Genet Metab. 2022 Sep-Oct;137(1-2):107-113. doi: 10.1016/j.ymgme.2022.07.015. Epub 2022 Aug 2.
No abstract available

Keywords: Accelerated approval; Biomarker; Drug development; Primary disease activity biomarker; Rare disease.

Publication types

  • Historical Article

MeSH terms

  • Drug Development*
  • History, 21st Century
  • Humans
  • United States
  • United States Food and Drug Administration